IJGC Podcast

By BMJ GroupMedicine Health & Fitness

IJGC Podcast episodes

November 13, 2020 Robotic vs Open Radical Hysterectomy: Pathology Interrogation with Javier Magrina
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Javier Magrina to discuss robotic vs open radical hysterectomy in pathology interrogation. Dr. Magrina is a Professor of Obstetrics and Gynecology at Mayo Graduate School of Medicine, and the recipient of the Barbara Woodward Lips Professorship. He is a staff consultant at Mayo Clinic Arizona.
Conclusions:
. robotic radical hysterectomy results in inferior survival as compared to laparotomy.
. robotic radical hysterectomy for early cervical cancer . intraperitoneal recurrences are not seen with laparotomy and appear due to the exfoliation and seeding of cervical cancer cells.
40 min
November 10, 2020 Psychosexual Morbidity in Women with Ovarian Cancer with Julia Pugh and Chloe Logue
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Julia Pugh and Chloe Logue to discuss psychosexual morbidity in women with ovarian cancer. Dr. Julia Pugh is a Gynaecology Clinical Nurse Specialist and psychosexual therapist based at The Christie Hospital in Manchester, UK. Dr. Pugh completed her Advanced Nursing Practice Masters at the University of Manchester and offers support for psychosexual concerns of men and women with cancer. Dr. Chloe Logue is a practicing junior doctor in Manchester. She completed her academic foundation at the Christie Cancer Hospital in Gynaecological Oncology, supervised by Prof Gordon Jayson.
Highlights:
- 75% of women with ovarian cancer experience psychosexual morbidity, exceeding published general population values.
- Key potential risk factors are: younger age, premenopausal status at diagnosis, extensive surgery, more courses of chemotherapy, cardiovascular co-morbidities and anxiety and depression.
- Common presenting symptoms include: vaginal dryness (81-87%) and pain (77%), amongst reduced sexual desire and activity, impaired orgasm, diminished perceived body image and reduced partner intimacy.
- The review identified that psychosexual issues are not routinely discussed nor adequately managed by clinicians. Psychosexual problems remain a priority for many women with ovarian cancer, many symptoms could be addressed by discussing their concerns and simple physical measures.
34 min
November 03, 2020 Reviewing the November Issue with Florencia Noll (Spanish Version)
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the November issue of IJGC in Spanish.
21 min
November 02, 2020 Outcomes of Ultra-radical Surgery in Ovarian Cancer with Sahar Salehi
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Sr. Sahar Salehi to discuss outcomes of ultra-radical surgery in ovarian cancer. Dr. Salehi is the Director of ovarian cancer surgery at Karolinska University Hospital, in Stockholm, Sweden, as well as an Assistant Professor at the Department of Microbiology, Tumor and Cellbiology at Karolinska Institutet.
• A shift to ultra-radical surgery does not improve survival despite increased complete resection rates, for this reason complete resection may not be the absolute aim in a high surgical proficiency setting.
• A shift to ultra-radical surgery increase the proportion of non-surgically treated women.
• The majority of women with cancer in the abdomen of unknown origin (inoperabel/non-resectable women/women who might not meet a gynecologic oncologist) are ovarian cancer patients.
• There is an urgent need to calibrate selection of patients to surgery (and to which extent of surgery) in more detail.
29 min
November 02, 2020 Reviewing the November Issue with Sadie Jones and Navya Nair (English Version)
In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the November issue of IJGC.
19 min
October 28, 2020 Results of the SCORPION Trial with Anna Fagotti
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti to discuss the results of the SCORPION trial. Dr. Fagotti is the lead author of "Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)", which is the Lead Article of IJGC’s November 2020 issue (https://ijgc.bmj.com/content/early/2020/10/07/ijgc-2020-001640).
Dr. Fagotti is the Ovarian Cancer Unit Director at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy, as well as an Associate Professor of Obstetrics and Gynecology at Università Cattolica del Sacro Cuore. Additionally, she is PhD Faculty of Biotechnology at University of Perugia, ESGO Council Member and Chair of the Educational Committee, as well as an Associate Editor for IJGC.
Highlights:
1. PDS and NACT ± IDS have superimposable median PFS and OS in patients with HTL ovarian cancer.
2. PDS has a higher rate of postoperative complications than IDS.
3. RT is the most powerful prognostic factor in AOC patients both at PDS and IDS"
32 min
October 20, 2020 Postoperative Complications of Epidural Analgesia with Sarah Ackroyd
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Sarah Ackroyd to discuss postoperative complications of epidural analgesia. Dr. Sarah Ackroyd is a gynecologic oncology fellow at the University of Chicago. Her research interests include health economics and outcomes research with a focus on decision analysis and patient-centered medical decision making. Dr. Sarah Ackroyd is a gynecologic oncology fellow at the University of Chicago. Her research interests include health economics and outcomes research with a focus on decision analysis and patient-centered medical decision making.
Main points:
- Our study utilizing the NSQIP database found that in a cohort of >2,000 patients who received an epidural at time of hysterectomy for cancer, there was a ~14% higher rate of minor complications including blood transfusions and superficial wound infection.
- Challenges of the epidural including hypotension and related complications, may be explained by the medication-induced sympathetic block that primarily prevents pain perception but can affect other sympathetic functions.J45
- Other studies in Gyn Oncology that utilized the epidural in an ERAS protocol demonstrate an overall improvement in postoperative pain scores, K43decreased opioid use, and no major complications.
- In the appropriate patient with the above findings considered, regional anesthesia such as the epidural, should be considered as part of a multi-modal pain approach.
29 min
October 13, 2020 Sexual Harassment in Gynecologic Oncology with Marina Stasenko
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Marina Stasenko to discuss sexual harassment in gynecologic oncology. Dr. Stasenko is a practicing gynecologic oncologist at the NYU Langone Hospital and recently completed her fellowship at the Memorial Sloan Kettering Cancer Center.
Highlights from the podcast:
- 64% of all gynecologic oncologist surveyed reported experience of sexual harassment in training or in practice.
- Only 14.5% reported the behavior.
- Female respondents were more likely to report that gender affected their career and compensation.
- Male respondents were more likely to report no gender disparity in income.
23 min
October 08, 2020 Reviewing the October Issue with Florencia Noll (Spanish Version)
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the October issue of IJGC in Spanish.
13 min
October 06, 2020 Reviewing the October Issue with Sadie Jones and Navya Nair (English Version)
In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the October issue of IJGC.
12 min

About IJGC Podcast

From the publisher's feed

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer.